ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition
CHAPEL HILL, N.C., April 21, 2026 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the HoT study (Menopausal Hormone Therapy for Women Living with HIV, also known as A5424), an essential new study with the potential to significantly expand the body of […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.